Literature DB >> 7632509

Idiopathic membranoproliferative glomerulonephritis in Japanese children.

K Iitaka1, T Ishidate, M Hojo, S Kuwao, N Kasai, T Sakai.   

Abstract

The course of idiopathic membranoproliferative glomerulonephritis (MPGN) in 41 Japanese children (21 boys, 20 girls) is reported. The mean follow-up period was 8 years, 9 months; 29 children with MPGN (71%) were identified by school urinary screening; 32 patients had type I MPGN, 2 type II and 7 type III; 10 patients were treated with multiple low-dose cocktail therapy (MLD), 8 with MLD followed by high-dose alternate-day (ALD) prednisolone and 21 with high-dose ALD prednisolone alone. In 1 patient, MPGN progressed to end-stage renal failure. The serum creatinine level in all of the remaining 40 patients was < or = 1.3 mg/dl at the last follow-up. Urinalysis was normal in 24 (59%). Of the 17 patients who still had urinary abnormalities, 4 had nephrotic syndrome. The incidence of remission of urinary abnormalities was highest in the patients treated with high-dose ALD prednisolone. Rebiopsy was performed in 33 patients, and revealed slight histological improvement in 11 (33%) patients, moderate improvement in 8 (24%), marked improvement in 5 (15%) and deterioration or no improvement in 9 patients (27%). Relatively few side effects of treatment were observed. The superior outcome of the MPGN patients in this compared with other studies may be the result of earlier detection and treatment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7632509     DOI: 10.1007/bf02254182

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  23 in total

1.  Idiopathic membranoproliferative glomerulonephritis in children. Report of 105 cases.

Authors:  R Habib; C Kleinknecht; M C Gubler; M Levy
Journal:  Clin Nephrol       Date:  1973 Jul-Aug       Impact factor: 0.975

2.  Childhood nephritis.

Authors:  A J McAdams; P T McEnergy; K E Bove; C D West
Journal:  Perspect Pediatr Pathol       Date:  1973

3.  Results of a controlled drug trial in membranoproliferative glomerulonephritis.

Authors:  D C Cattran; C J Cardella; J M Roscoe; R C Charron; P C Rance; S M Ritchie; P N Corey
Journal:  Kidney Int       Date:  1985-02       Impact factor: 10.612

4.  Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.

Authors:  J V Donadio; C F Anderson; J C Mitchell; K E Holley; D M Ilstrup; V Fuster; J H Chesebro
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

5.  Morphology and serum complement levels in membranoproliferative glomerulonephritis.

Authors:  R Habib; C Loirat; M Gubler; M Levy
Journal:  Adv Nephrol Necker Hosp       Date:  1974

6.  Treatment of chronic glomerulonephritis with a combination of indomethacin and cyclophosphamide.

Authors:  Y Vanrenterghem; L Roels; R Verberckmoes; P Michielsen
Journal:  Clin Nephrol       Date:  1975-12       Impact factor: 0.975

7.  Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy.

Authors:  P T McEnery; A J McAdams; C D West
Journal:  Clin Nephrol       Date:  1980-03       Impact factor: 0.975

8.  Hypocomplementaemia and membranoproliferative glomerulonephritis in school urinary screening in Japan.

Authors:  K Iitaka; S Igarashi; T Sakai
Journal:  Pediatr Nephrol       Date:  1994-08       Impact factor: 3.714

9.  Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.

Authors:  C F Strife; A J McAdams; C D West
Journal:  Clin Nephrol       Date:  1982-07       Impact factor: 0.975

10.  Childhood membranoproliferative glomerulonephritis type I: limited steroid therapy.

Authors:  D M Ford; D M Briscoe; P F Shanley; G M Lum
Journal:  Kidney Int       Date:  1992-06       Impact factor: 10.612

View more
  6 in total

1.  Efficacy of school urinary screening for membranoproliferative glomerulonephritis type 1.

Authors:  Y Kawasaki; J Suzuki; R Nozawa; H Suzuki
Journal:  Arch Dis Child       Date:  2002-01       Impact factor: 3.791

2.  Long-term follow-up of atypical membranoproliferative glomerulonephritis: are steroids indicated?

Authors:  Teruo Fujita; Kandai Nozu; Kazumoto Iijima; Ichiro Kamioka; Kunihiko Yoshiya; Ryojiro Tanaka; Kiyoshi Hamahira; Koichi Nakanishi; Norishige Yoshikawa; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2005-10-25       Impact factor: 3.714

3.  Long-term follow-up of diffuse membranoproliferative glomerulonephritis type I.

Authors:  Takeshi Yanagihara; Mari Hayakawa; Junko Yoshida; Masami Tsuchiya; Toshisada Morita; Mutsumi Murakami; Yoshitaka Fukunaga
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

4.  Focal segmental membranoproliferative glomerulonephritis in children.

Authors:  Kikuo Iitaka; Shinya Nakamura; Shunsuke Moriya; Osamu Motoyama; Tadasu Sakai
Journal:  Pediatr Nephrol       Date:  2003-07-23       Impact factor: 3.714

5.  Transition of children with membranoproliferative glomerulonephritis to adolescence and adulthood.

Authors:  Kikuo Iitaka; Osamu Motoyama; Shinya Nakamura; Hiroe Koshino; Tadasu Sakai
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

6.  Usefulness of an automated urinary flow cytometer in mass screening for nephritis.

Authors:  Kazunari Kaneko; Mutsumi Murakami; Kazumi Shiraishi; Masaru Matsumoto; Kuniaki Yamauchi; Teruo Kitagawa; Yuichiro Yamashiro
Journal:  Pediatr Nephrol       Date:  2004-03-12       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.